Tag: FDA Approval
Lupin Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
Lupin Limited has received approval from the U.S. FDA for its Prednisolone Acetate Ophthalmic Suspension USP, 1%, a generic version of AbbVie's Pred Forte....
Lupin Completes Phase 3 Trials for Lucentis Biosimilar
Lupin Limited announced the successful completion of global Phase 3 trials for its Lucentis (ranibizumab) biosimilar, LUBT010. This trial, involving 600 patients from India,...
